(2S,5R)-N-[(2S)-azetidin-2-ylmethoxy]-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide | 1572987-60-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2S,5R)-N-[(2S)-azetidin-2-ylmethoxy]-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
• 英文别名: (2S,5R)-N-[(2S)-azetidin-2-ylmethyloxy]-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide；[(2S,5R)-2-[[(2S)-azetidin-2-yl]methoxycarbamoyl]-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate
• CAS: 1572987-60-0
• 化学式: C₁₁H₁₈N₄O₇S
• 分子量: 350.353
• InChiKey: FFVLCXRLLUGPDD-YIZRAAEISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.9
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  146
• 氢给体数：
  3
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  tetrabutylammonium tert-butyl (2S)-2-{[({[(2S,5R)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]oct-2-yl]carbonyl}amino)oxy]methyl}azetidine-1-carboxylate 在 三氟乙酸 作用下， 以172.3 mg的产率得到(2S,5R)-N-[(2S)-azetidin-2-ylmethoxy]-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
  参考文献：
  名称：

  CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF

  摘要：

  一种由以下化学式（VII）表示的二氮杂双环辛烷衍生物的结晶形式，以及生产该衍生物的方法：

  公开号：

  US20160272641A1

文献信息

• 1,6- DIAZABICYCLO [3,2,1] OCTAN-7-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
  申请人：Patil Vijaykumar Jagdishwar

  公开号：US20150203503A1

  公开（公告）日：2015-07-23

  Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.

  公式（I）化合物的制备和在预防或治疗细菌感染中的用途被披露。
• [EN] 1,6- DIAZABICYCLO [3,2,1] OCTAN- 7- ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] DÉRIVÉS DE 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE ET LEUR UTILISATION DANS LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
  申请人：WOCKHARDT LTD

  公开号：WO2014033560A1

  公开（公告）日：2014-03-06

  Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.

  公开了化合物(I)的结构式，它们的制备方法以及在预防或治疗细菌感染中的用途。
• NOVEL BETA-LACTAMASE INHIBITOR AND PROCESS FOR PREPARING THE SAME
  申请人：MEIJI SEIKA PHARMA CO., LTD.

  公开号：US20150141401A1

  公开（公告）日：2015-05-21

  A diazabicyclooctane compound, which is a beta-lactame inhibitor, represented by the following formula (I): wherein A represents Ra(Rb)N— or RcO—; B represents NH or NC 1-6 alkyl; C represents benzyl, H or SO 3 M, wherein M represents H, an inorganic or an organic cation; Ra and Rb represent H, C 1-6 alkyl or acyl; Rc represents C 1-6 alkyl or a heterocyclyl; A is unsubstituted or substituted with 0 to 4 substituents Fn1, wherein Fn1 represents C 1-6 alkyl, O═, or Rg-(CH 2 ) 0-3 —, wherein Rg represents a heterocyclyl, phenyl, heteroaryl, acyl, RdO 2 S—, Re(Rf)N—, Re(Rf)NCO—, ReO—, ReOCO— or a protective group, wherein Rd represents C 1-6 alkyl or MO—; Re and Rf represent H or C 1-6 alkyl, and a heterocycle having at least one nitrogen atom may be formed between Ra and Rb, between Rc and B, or between Re and Rf.

  这是一种二氮杂双环辛烷化合物，是一种β-内酰胺酶抑制剂，化学式为(I)，其中A代表Ra(Rb)N—或RcO—；B代表NH或NC1-6烷基；C代表苄基、氢或SO3M，其中M代表氢、无机或有机阳离子；Ra和Rb代表氢、C1-6烷基或酰基；Rc代表C1-6烷基或杂环基；A未被取代或被0至4个取代基Fn1取代，其中Fn1代表C1-6烷基、O═或Rg-(CH2)0-3—，其中Rg代表杂环基、苯基、杂环芳基、酰基、RdO2S—、Re(Rf)N—、Re(Rf)NCO—、ReO—、ReOCO—或保护基，其中Rd代表C1-6烷基或MO—；Re和Rf代表氢或C1-6烷基，Ra和Rb之间、Rc和B之间或Re和Rf之间可以形成至少一个含有氮原子的杂环。
• 1,6- DIAZABICYCLO [3,2,1] OCTAN- 7- ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
  申请人：WOCKHARDT LIMITED

  公开号：US20160213655A1

  公开（公告）日：2016-07-28

  Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.

  公开了式（I）的化合物，它们的制备和用于预防或治疗细菌感染的用途。
• PROCESS FOR PRODUCING DIAZABICYCLOOCTANE DERIVATIVE AND INTERMEDIATE THEREOF
  申请人：MEIJI SEIKA PHARMA CO., LTD.

  公开号：US20160264573A1

  公开（公告）日：2016-09-15

  A process for producing a diazabicyclooctane derivative represented by Formula (IV) and intermediates thereof by carrying out the following steps: wherein P is an NH protecting group capable of being removed with acid; R 1 is 2,5-dioxopyrrolidin-1-yl, 1,3-dioxo-3a,4,7,7a-tetrahydro-1H-isoindol-2(3H)-yl, 1,3-dioxohexahydro-1H-isoindol-2(3H)-yl, or 3,5-dioxo-4-azatricyclo[5.2.1.0 2.6 ]dec-8-en-4-yl; R 2 is hydrogen, ClCO— or Cl 3 COCO—; R 3 is C 1-6 alkyl or heterocyclyl, or forms a 3- to 7-membered heterocyclic ring together with the —O—NH— to which it is attached; and OBn is benzyloxy.

  通过以下步骤生产由公式（IV）表示的二氮杂双环辛烷衍生物及其中间体： 其中P是可用酸去除的NH保护基；R1是2,5-二氧代吡咯烷-1-基，1,3-二氧代-3a,4,7,7a-四氢-1H-异吲哚-2（3H）-基，1,3-二氧代六氢-1H-异吲哚-2（3H）-基，或3,5-二氧代-4-氮杂三环[5.2.1.0²，⁶]癸-8-烯-4-基；R2是氢，ClCO-或Cl3COCO-；R3是C1-6烷基或杂环基，或与其连接的-O-NH-一起形成3-至7-成员的杂环；OBn是苄氧基。